The rational application of liquid biopsy based on next‐generation sequencing in advanced non‐small cell lung cancer

BACKGROUND: Plasma and tissue biopsy have both used for targeting actionable driver gene mutations in lung cancer, whose concordance is imperfect. A reliable method to predict the concordance is urgently needed to ease clinical application. METHODS: A total of 1012 plasma samples, including 519 with...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Chenglong, Li, Jianghua, Zhang, Yongchang, Han, Rui, Wang, Yubo, Li, Li, Zhang, Yimin, Zhu, Mengxiao, Zheng, Jie, Du, Haiwei, Hu, Chen, Zhou, Chengzhi, Yang, Nong, Cai, Shangli, He, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028052/
https://www.ncbi.nlm.nih.gov/pubmed/36341686
http://dx.doi.org/10.1002/cam4.5410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028052/
https://www.ncbi.nlm.nih.gov/pubmed/36341686
http://dx.doi.org/10.1002/cam4.5410

Ejemplares similares